These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes. Ferber KM; Keller E; Albert ED; Ziegler AG J Clin Endocrinol Metab; 1999 Jul; 84(7):2342-8. PubMed ID: 10404800 [TBL] [Abstract][Full Text] [Related]
5. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry. Gorus FK; Goubert P; Semakula C; Vandewalle CL; De Schepper J; Scheen A; Christie MR; Pipeleers DG Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724 [TBL] [Abstract][Full Text] [Related]
6. Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test. Wiest-Ladenburger U; Hartmann R; Hartmann U; Berling K; Böhm BO; Richter W Diabetes; 1997 Apr; 46(4):565-71. PubMed ID: 9075795 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus. Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591 [TBL] [Abstract][Full Text] [Related]
8. HLA-DQB1 genotypes and islet cell autoantibodies against GAD65 and IA-2 in relation to development of diabetes post partum in women with gestational diabetes mellitus. Papadopoulou A; Lynch KF; Anderberg E; Landin-Olsson M; Hansson I; Agardh CD; Lernmark Å; Berntorp K Diabetes Res Clin Pract; 2012 Feb; 95(2):260-4. PubMed ID: 22104260 [TBL] [Abstract][Full Text] [Related]
9. Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group. Petersen JS; Dyrberg T; Karlsen AE; Mølvig J; Michelsen B; Nerup J; Mandrup-Poulsen T Diabetes; 1994 Nov; 43(11):1291-6. PubMed ID: 7926302 [TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM). Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039 [TBL] [Abstract][Full Text] [Related]
11. Anti-GAD65 autoantibody in Taiwanese patients with insulin-dependent diabetes mellitus: effect of HLA on anti-GAD65 positivity and clinical characteristics. Chuang LM; Lin CY; Wu HP; Tsai WY; Tai TY; Lin BJ Clin Endocrinol (Oxf); 1997 Oct; 47(4):455-61. PubMed ID: 9404444 [TBL] [Abstract][Full Text] [Related]
12. Women diagnosed with gestational diabetes mellitus do not carry antibodies against minor islet cell antigens. Balaji M; Shtauvere-Brameus A; Balaji V; Seshiah V; Sanjeevi CB Ann N Y Acad Sci; 2002 Apr; 958():281-4. PubMed ID: 12021124 [TBL] [Abstract][Full Text] [Related]
13. Human B cells secreting immunoglobulin G to glutamic acid decarboxylase-65 from a nondiabetic patient with multiple autoantibodies and Graves' disease: a comparison with those present in type 1 diabetes. Tremble J; Morgenthaler NG; Vlug A; Powers AC; Christie MR; Scherbaum WA; Banga JP J Clin Endocrinol Metab; 1997 Aug; 82(8):2664-70. PubMed ID: 9253351 [TBL] [Abstract][Full Text] [Related]
14. High prevalence of autoantibodies to glutamic acid decarboxylase in long-standing IDDM is not a marker of symptomatic autonomic neuropathy. Zanone MM; Petersen JS; Peakman M; Mathias CJ; Watkins PJ; Dyrberg T; Vergani D Diabetes; 1994 Sep; 43(9):1146-51. PubMed ID: 8070615 [TBL] [Abstract][Full Text] [Related]
15. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. Kim J; Namchuk M; Bugawan T; Fu Q; Jaffe M; Shi Y; Aanstoot HJ; Turck CW; Erlich H; Lennon V; Baekkeskov S J Exp Med; 1994 Aug; 180(2):595-606. PubMed ID: 7519242 [TBL] [Abstract][Full Text] [Related]
16. Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study. Füchtenbusch M; Ferber K; Standl E; Ziegler AG Diabetes; 1997 Sep; 46(9):1459-67. PubMed ID: 9287047 [TBL] [Abstract][Full Text] [Related]
17. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. Tuomi T; Björses P; Falorni A; Partanen J; Perheentupa J; Lernmark A; Miettinen A J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356 [TBL] [Abstract][Full Text] [Related]
18. Value of antibodies to GAD65 combined with islet cell cytoplasmic antibodies for predicting IDDM in a childhood population. Aanstoot HJ; Sigurdsson E; Jaffe M; Shi Y; Christgau S; Grobbee D; Bruining GJ; Molenaar JL; Hofman A; Baekkeskov S Diabetologia; 1994 Sep; 37(9):917-24. PubMed ID: 7806022 [TBL] [Abstract][Full Text] [Related]
19. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Petersen JS; Hejnaes KR; Moody A; Karlsen AE; Marshall MO; Høier-Madsen M; Boel E; Michelsen BK; Dyrberg T Diabetes; 1994 Mar; 43(3):459-67. PubMed ID: 8314020 [TBL] [Abstract][Full Text] [Related]
20. The prevalence of GAD antibodies in Korean women with gestational diabetes mellitus and their clinical characteristics during and after pregnancy. Yu SH; Park S; Kim HS; Park SY; Yim CH; Han KO; Yoon HK; Jang HC; Chung HY; Kim SH Diabetes Metab Res Rev; 2009 May; 25(4):329-34. PubMed ID: 19405080 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]